Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2022
Title: Xianzhi Wu: Innovator in Pharmaceutical Modulation
Introduction
Xianzhi Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of indoleamine 2,3-dioxygenase. His work focuses on developing compounds that can be used in treating various diseases.
Latest Patents
Xianzhi Wu holds a patent for a "Modulator of indoleamine 2,3-dioxygenase, preparation method and use thereof." This invention relates to a modulator of 1,2,5-oxadiazole indoleamine-(2,3)-dioxygenase. It includes compounds of Formula I and Formula II, their isomers, pharmaceutically acceptable salts, and solvates. The patent outlines their use in preparing drugs for treating cancers, neurodegenerative diseases, eye diseases, mental disorders, depression, anxiety disorders, Alzheimer's diseases, and autoimmune diseases.
Career Highlights
Throughout his career, Xianzhi Wu has worked with prominent pharmaceutical companies, including Nanjing Carephar Shenghui Pharmaceutical Co., Ltd. and Jiangsu Carephar Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Xianzhi Wu has collaborated with notable colleagues, including Yinlin Qin and Mei Su. These partnerships have enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Xianzhi Wu is a distinguished inventor whose work in pharmaceutical modulation has the potential to impact the treatment of various diseases significantly. His innovative approach and dedication to research continue to drive advancements in the field.